The Global Health Body Issues Warning Over Severe Lack of Weight-Loss Medications
Less than a tenth of patients eligible to benefit from obesity jabs such as Wegovy can access them, warns the global health agency as it releases its first advice on the medications.
Given over a billion individuals worldwide now living with obesity, it is calling for more widespread and fairer availability to this class of drugs.
Per projections, more than two billion are projected to be living with obesity by 2030 if no action is taken.
"The latest guidance recognises that obesity is a long-term condition that can be treated with thorough and continuous treatment," stated the agency's head Tedros Adhanom Ghebreyesus.
High costs, insufficient output, and logistical bottlenecks are key barriers to universal access to the injections that can aid individuals in losing considerable body mass, notes the agency.
GLP-1 Therapy Supply Crisis
Even in the present most optimistic outlook, the production of such drugs might only reach around 100 million people – fewer than 10% of those who need them, as stated by the health organization.
The guideline urges countries and companies to widen availability, via strategies like voluntary licensing.
The intellectual property rights on the active ingredient – the primary component of a leading brand – is scheduled to end in a number of nations in 2026.
How Obesity Injections Function
These medications imitate a biological compound to delay gastric emptying, reduce hunger and enhance the sense of being full so people reduce food intake.
People commonly see weight reduction within a few weeks of commencing the weekly injections.
Research points to patients may put most of the weight back on after a year of halting the treatment, because their usual appetite come back.
To be carrying excess weight raises your likelihood for developing health problems, like diabetes, cardiovascular issues, stroke, and certain cancers.
Excess weight impacts people in countries worldwide and was linked to 3.7 million deaths worldwide in 2024, according to the WHO.
